Lunai Bioworks Inc LNAI

$1.30 -0.08 (-5.80%)

Valuation

Market cap
6,257,000
Revenue TTM
$0
Net income TTM
$-178,010,000
PE ratio
0.00
Forward PE
—
Profit margin
0.00%
Debt to equity
0.00

Trading

Volume
124,900
Avg volume
221,644
Day's range
$1.23 – $1.46
Shares out
4,534,000
Stochastic %K
5%
Beta
0.37
Analysts
Strong Buy
Price target
—

Price

Company profile

Lunai Bioworks Inc., a pre-clinical stage biotechnology company, provides medicine, diagnostics, and biodefense products the United States and the Netherlands. It operates through three segments, RENB, BioSymetrics, and RENC. The company is developing a genetically modified allogeneic dendritic cell therapeutic vaccines, including RENB-DC11 to treat solid tumors primarily for pancreatic tumors; and RENB-DC20 for the...

Show more

Lunai Bioworks Inc., a pre-clinical stage biotechnology company, provides medicine, diagnostics, and biodefense products the United States and the Netherlands. It operates through three segments, RENB, BioSymetrics, and RENC. The company is developing a genetically modified allogeneic dendritic cell therapeutic vaccines, including RENB-DC11 to treat solid tumors primarily for pancreatic tumors; and RENB-DC20 for the treatment of breast cancer. It also develops an artificial intelligence platform technology for early cancer detection and its recurrence that uses a multi-omics approach to search for individual biomarkers that are present even in asymptomatic patients. The company was formerly known as Renovaro Inc. and changed its name to Lunai Bioworks Inc. in August 2025. Lunai Bioworks Inc. is headquartered in Los Angeles, California.

Industry
Biotechnology
Sector
Healthcare
Phone
305 918 1980
Website
https://www.lunaibioworks.com
Address
2080 Century Park East, Suite 906, Los Angeles, United States

Latest news

Stocktwits

Damotitan Oct 2, 7:35 PM
$LNAI at the 1y low, expecting the filing Monday, looking like a lovely setup
0 replies
LuckyEnzo Oct 1, 5:50 PM
@EquivalentExchange is on an absolute tear recently🔥the plays just keep getting better! If you’re not following yet you’re missing out. $NXTS $LNAI $MWG ripe
0 replies
flatrock100 Oct 1, 10:33 AM
$LNAI could be huge
0 replies
11thestate Sep 29, 1:38 PM
$ENOB (now $LNAI) stock dropped more than 50% after the company’s co-founder was arrested and reports revealed his history of fraud and falsified credentials, ending up in a $2.5 million investor settlement. If you bought or held $ENOB between 2018 and 2022, you may still be able to recover losses, late claims are currently being considered. Check if you're eligible and file a claim: https://11th.com/cases/enochian-biosciences-investor-settlement
0 replies
Damotitan Sep 22, 1:27 PM
$LNAI big potential here
0 replies
IAmMsMoneyMaker Sep 22, 1:26 PM
$LNAI TIMING IS EVERYTHING…GOING UP! 🚀 💥 🚀 💥 🚀 💥 🚀 💥 🚀 💥 🚀 💥
0 replies
flychicken1991 Sep 22, 1:24 PM
$LNAI Lunai Bioworks (NASDAQ: LNAI) Expands Parkinson's Platform Through Exclusive Tanaist Agreement. Impact: Positive (72%). shares could face modest upward price pressure as the agreement expands the company's Parkinson's research capabilities and gives it ownership of collaboration-generated findings... Source and what to watch next: https://nimpact.tech/newsimpact/news/14deea6368a9b513/lnai-lunai-bioworks-nasdaq-lnai-expands-parkinson-s-platform-through-exc?utm_source=stocktwits&utm_medium=story_url
0 replies
Stock_Catcher Sep 22, 1:22 PM
$LNAI Lunai Bioworks (NASDAQ: LNAI) Expands Parkinson's Platform Through Exclusive Tanaist Agreement
0 replies